Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines



   thyrotoxic periodic paralysis
  

Disease ID 1448
Disease thyrotoxic periodic paralysis
Synonym
hashitoxic periodic paralysis
paralysis periodic thyrotoxic
thyrotoxic periodic paralysis (disorder)
Orphanet
UMLS
C0268446
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:5)
C0018213  |  graves' disease  |  3
C0040156  |  thyrotoxicosis  |  3
C0020550  |  hyperthyroidism  |  1
C0033975  |  psychosis  |  1
C1145670  |  respiratory failure  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:3)
KCNJ18  |  100134444  |  CLINVAR;ORPHANET
CACNA1S  |  779  |  CLINVAR;ORPHANET
GABRA3  |  2556  |  ORPHANET
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:8)
476  |  ATP1A1  |  infer
477  |  ATP1A2  |  infer
481  |  ATP1B1  |  infer
482  |  ATP1B2  |  infer
23439  |  ATP1B4  |  infer
779  |  CACNA1S  |  infer
6329  |  SCN4A  |  infer
6331  |  SCN5A  |  infer
Text Mined Gene(Waiting for update.)
Locus(Waiting for update.)
Disease ID 1448
Disease thyrotoxic periodic paralysis
Integrated Phenotype
HPO | Name(Total Integrated Phenotypes:42)
HP:0001824  |  Weight loss
HP:0002019  |  Constipation
HP:0008285  |  Transient hypophosphatemia
HP:0003394  |  Muscle cramps
HP:0002917  |  Hypomagnesemia
HP:0012726  |  Episodic hypokalemia
HP:0008180  |  Mildly elevated creatine phosphokinase
HP:0005165  |  Shortened PR interval
HP:0003470  |  Paralysis
HP:0012364  |  Decreased urinary potassium
HP:0001657  |  Prolonged QT interval
HP:0012240  |  Increased intramyocellular lipid droplets
HP:0003134  |  Abnormality of peripheral nerve conduction
HP:0002445  |  Tetraplegia
HP:0002486  |  Myotonia
HP:0001663  |  Ventricular fibrillation
HP:0001513  |  Obesity
HP:0000836  |  Hyperthyroidism
HP:0003457  |  EMG abnormality
HP:0007340  |  Lower limb muscle weakness
HP:0000975  |  Hyperhidrosis
HP:0003201  |  Rhabdomyolysis
HP:0011784  |  Thyrotoxicosis with diffuse goiter
HP:0011786  |  Thyrotoxicosis with toxic single thyroid nodule
HP:0000597  |  Ophthalmoparesis
HP:0003752  |  Episodic flaccid weakness
HP:0011785  |  Thyrotoxicosis with toxic multinodular goitre
HP:0002153  |  Hyperkalemia
HP:0008153  |  Periodic hypokalemic paresis
HP:0003552  |  Muscle stiffness
HP:0000016  |  Urinary retention
HP:0100647  |  Graves disease
HP:0011706  |  Second degree atrioventricular block
HP:0001962  |  Palpitations
HP:0009020  |  Exercise-induced muscle fatigue
HP:0004303  |  Abnormality of muscle fibers
HP:0006670  |  Impaired myocardial contractility
HP:0003694  |  Late-onset proximal muscle weakness
HP:0001265  |  Hyporeflexia
HP:0002203  |  Respiratory paralysis
HP:0011998  |  Postprandial hyperglycemia
HP:0001337  |  Tremor
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:8)
HP:0003690  |  Limb weakness  |  1
HP:0002900  |  Hypokalemia  |  1
HP:0000709  |  Psychosis  |  1
HP:0000836  |  Overactive thyroid  |  1
HP:0001695  |  Cardiac arrest  |  1
HP:0002878  |  Respiratory failure  |  1
HP:0007340  |  Lower limb weakness  |  1
HP:0002153  |  Elevated serum potassium levels  |  1
Disease ID 1448
Disease thyrotoxic periodic paralysis
Manually Symptom(Waiting for update.)
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:1)
C1145670  |  respiratory failure  |  1
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:12)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs1325310NA779CACNA1Sumls:C0268446CLINVARNA0.242909916NACACNA1S1201110107CT
rs2281845NA779CACNA1Sumls:C0268446CLINVARNA0.242909916NACACNA1S1201112815CT
rs527236151NA100134444KCNJ18umls:C0268446CLINVARNA0.240542884NAKCNJ181721702913CT
rs527236152NA100134444KCNJ18umls:C0268446CLINVARNA0.240542884NAKCNJ181721703205CT
rs527236153NA100134444KCNJ18umls:C0268446CLINVARNA0.240542884NAKCNJ181721703215C-
rs527236154NA100134444KCNJ18umls:C0268446CLINVARNA0.240542884NAKCNJ181721703288GA
rs527236155NA100134444KCNJ18umls:C0268446CLINVARNA0.240542884NAKCNJ181721703384GC
rs527236156NA100134444KCNJ18umls:C0268446CLINVARNA0.240542884NAKCNJ181721703981CT
rs527236157NA100134444KCNJ18umls:C0268446CLINVARNA0.240542884NAKCNJ181721704005CT
rs527236158NA100134444KCNJ18umls:C0268446CLINVARNA0.240542884NAKCNJ181721703847CT
rs527236159NA100134444KCNJ18umls:C0268446CLINVARNA0.240542884NAKCNJ181721703883AG
rs623011229105843759KCNJ2umls:C0268446BeFreeA recent genome-wide association study of Thai patients with thyrotoxic periodic paralysis (TPP) identified a novel genetic variant rs623011 located in chromosome 17q24.3, which may potentially reduce the transcription of Kir2.1 and total Kir current.0.0005428842012NA1770263305AG
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Chemical(Total Drugs:0)
(Waiting for update.)
FDA approved drug and dosage information(Total Drugs:0)
(Waiting for update.)
FDA labeling changes(Total Drugs:0)
(Waiting for update.)